Within-Trial Cost and 1-Year Cost-Effectiveness of the DiRECT/Counterweight-Plus Weight-Management Programme to Achieve Remission of Type 2 Diabetes

The Lancet Diabetes and Endocrinology - Netherlands
doi 10.1016/s2213-8587(18)30346-2

Related search